Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
Cancer cells that survive initial drug treatment can persist in the presence of drugs. Here, the authors generate persister cells that are resistant to the EGFR tyrosine kinase inhibitor erlotinib and show by single cell analysis that multiple mechanism give rise to the drug-resistant persister stat...
Enregistré dans:
Auteurs principaux: | Michael Ramirez, Satwik Rajaram, Robert J. Steininger, Daria Osipchuk, Maike A. Roth, Leanna S. Morinishi, Louise Evans, Weiyue Ji, Chien-Hsiang Hsu, Kevin Thurley, Shuguang Wei, Anwu Zhou, Prasad R. Koduru, Bruce A. Posner, Lani F. Wu, Steven J. Altschuler |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bd1a3c50ad1a402d9bff233756a1c84e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Analysis of growth cone extension in standardized coordinates highlights self-organization rules during wiring of the Drosophila visual system.
par: Weiyue Ji, et autres
Publié: (2021) -
Analysis of growth cone extension in standardized coordinates highlights self-organization rules during wiring of the Drosophila visual system
par: Weiyue Ji, et autres
Publié: (2021) -
Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
par: Roth SH
Publié: (2011) -
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
par: Rajeswara Rao Arasada, et autres
Publié: (2018) -
Brain-targeted drug delivery by manipulating protein corona functions
par: Zui Zhang, et autres
Publié: (2019)